UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000005498 |
|---|---|
| Receipt number | R000006520 |
| Scientific Title | Sitagliptin Add-on to Sulfonylurea Study |
| Date of disclosure of the study information | 2011/04/25 |
| Last modified on | 2014/12/25 19:31:22 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Sitagliptin Add-on to Sulfonylurea Study
Acronym
Sitagliptin A Study
Scientific Title
Sitagliptin Add-on to Sulfonylurea Study
Scientific Title:Acronym
Sitagliptin A Study
Region
| Japan |
Condition
Condition
type 2 diabetes
Classification by specialty
| Endocrinology and Metabolism |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess the effect of sitagliptin on glycemic control and beta-cell function in oral hypoglycemic agents-treated patients with type 2 diabetes
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Change in HbA1c
Key secondary outcomes
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Add on sitagliptin to other oral hypoglycemic agents
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
1. Patients with type 2 diabetes
2. Patients who have a will to diet and exercise
3. HbA1c 6.5%=or<, 10.0%>
4. No improvement in HbA1c >or= 0.5% within 3 months
5. Patients treated with SU (glimepride or gliclazide), metformin, TZD or alphaGI
6. Aged >or= 20 years
7. Both female and male
8. Written informed consent by patients
Key exclusion criteria
1. Type 1 diabetes; secondary diabetes
2. Alcoholism; severe depression or severe psychological condition
3. Malignancy
4. Patients treated with insulin
5. Abnormal hemoglobinemia
6. Patients unsuitable for this study judged by physicians
Target sample size
80
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Shinichi Harashima |
Organization
Kyoto University
Division name
Department of Diabetes and Clinical Nutrition
Zip code
Address
54 Syogoin Kawaramachi Sakyo-ku Kyoto
TEL
075-751-3560
harasima@metab.kuhp.kyoto-u.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Shinichi Harashima |
Organization
Kyoto University
Division name
Department of Diabetes and Clinical Nutrition
Zip code
Address
54 Syogoin Kawaramachi Sakyo-ku Kyoto
TEL
075-751-3560
Homepage URL
harasima@metab.kuhp.kyoto-u.ac.jp
Sponsor or person
Institute
Kyoto University
Institute
Department
Personal name
Funding Source
Organization
Kyoto University
Takashima General Hospital
Organization
Division
Category of Funding Organization
Self funding
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2011 | Year | 04 | Month | 25 | Day |
Related information
URL releasing protocol
Publication of results
Published
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2010 | Year | 02 | Month | 01 | Day |
Date of IRB
Anticipated trial start date
| 2010 | Year | 02 | Month | 01 | Day |
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2011 | Year | 04 | Month | 24 | Day |
Last modified on
| 2014 | Year | 12 | Month | 25 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006520
